Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:public_company
|
| gptkbp:CEO |
gptkb:James_Hollingshead
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:CUSIP |
45784P101
|
| gptkbp:filingsInclude |
https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001145197
|
| gptkbp:foundedYear |
2000
|
| gptkbp:hasCompany |
gptkb:Insulet_Corporation
|
| gptkbp:headquartersLocation |
gptkb:Acton,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
NASDAQ:PODD
|
| gptkbp:industry |
medical devices
|
| gptkbp:ISIN |
US45784P1012
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:marketCap |
large cap
|
| gptkbp:numberOfEmployees |
over 2000
|
| gptkbp:product |
gptkb:Omnipod_insulin_management_system
|
| gptkbp:stockSymbol |
gptkb:PODD
|
| gptkbp:tradedOn |
gptkb:NASDAQ:PODD
|
| gptkbp:website |
https://www.insulet.com/
|
| gptkbp:bfsParent |
gptkb:Insulet
|
| gptkbp:bfsLayer |
6
|